Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature.

NCT01756547 is registered in ClinicalTrials.gov with Juan A. Arnaiz as lead sponsor.

NCT NCT01756547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature.
Lead sponsor
Juan A. Arnaiz
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2013
Completion date
January 31, 2014
Enrollment
74 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrocalcinosis